Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/16/2004US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004US6818748 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against Venezuelan equine encephalitis virus (VEE)
11/16/2004US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004US6818743 Intercellular adhesion molecule (i-cam) for modulation of ligand/receptor binding/cloning reactions; drug screening of antiinflammatory/anticancer agents; genetic engineering
11/16/2004US6818742 Stable radioiodine conjugates and methods for their synthesis
11/16/2004US6818741 Alpha-fetoprotein peptides and uses therof
11/16/2004US6818627 Nuclear localization sequence fragment of hiv-1 vpr protein conjugated to nucleotide; drug delivery, antiproliferative agents
11/16/2004US6818456 Color contrast system for lateral flow immunoassay tests
11/16/2004US6818455 Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
11/16/2004US6818454 Monitoring phosphorylation states of one or more proteins; obtain protein sample, incubate with label, monitor sample for signal from bound proteins
11/16/2004US6818453 Comprises 8-aza bicyclo(3,2,1) octane bridge structure and maleimide moiety
11/16/2004US6818452 Lateral flow contact test apparatus
11/16/2004US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004US6818443 Fluorescent proteins
11/16/2004US6818420 Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
11/16/2004US6818416 Determining the ration of glycated and nonglycated hemoglobin in sample; obtain blood sample, incubate with substrate, separate unbound substrate, determine ratio of glycated to non-glycated hemoglobin in sample
11/16/2004US6818414 Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same
11/16/2004US6818413 Fluorescence-based high throughput screening assays for protein kinases and phosphatases
11/16/2004US6818411 Retentate chromatography and protein chip arrays with applications in biology and medicine
11/16/2004US6818410 Methods of isolating RNA-binding proteins and compositions related to the same
11/16/2004US6818408 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate
11/16/2004US6818406 Diagnosing arthritis in mammals; obtain sample, incubate with marker protein probe, determine marker protein concentration, evaluate for arthritis
11/16/2004US6818403 Monitoring migration of preferential particles; obtain cell solution, insert into container, monitor and evaluate migration of cells
11/16/2004US6818402 Diagnosis of parasitic infections; obtain sample, extract nucleotide sequences, incubate with primer, amplify sequences, separate products, incubate with probes and detect signal, presence of signal indicates presence of parasite
11/16/2004US6818400 Process for producing biochip
11/16/2004US6818396 Process for determination of the activity of a substance using an in vitro functional test
11/16/2004US6818394 High density immobilization of nucleic acids
11/16/2004US6818392 Monoclonal antibodies to human immunodeficiency virus and uses thereof
11/16/2004US6818259 Remote plasma discharge process is preferably conducted so that no photons, and particularly no ultraviolet radiation, is transmitted from the plasma glow to the porous article
11/16/2004US6818219 Reagent for detecting and monitoring viral infections
11/16/2004US6818217 Immunoreactive peptides
11/16/2004US6818210 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/16/2004US6818200 Modification of the molecular structure of dihydropyridine family drug containing one or more hydrogen atoms by deuterating one or more hydrogen atoms to deuterium atoms; improved activity over the known drug
11/16/2004US6818199 Intravenous delivery of radiographic nanoparticulate contrast agent
11/16/2004US6818184 Capillary array and related methods
11/16/2004US6818181 Kit and method for detecting food allergies
11/16/2004US6818180 Devices for testing for the presence and/or concentration of an analyte in a body fluid
11/16/2004US6818120 Includes an input resistance changing portion to detect breaking of signal wires on the basis of output voltages of the sensors without increasing pollutant emissions of the auto exhaust system
11/16/2004US6817754 Fuel freezing point monitoring device
11/16/2004US6817238 Cement expansion/contraction test apparatus
11/16/2004US6817230 Systems and methods for determining the absorption and specific gravity properties of compacted and loose material including fine and coarse aggregates
11/16/2004US6817227 Aboveground leak detection system for detecting sub-surface fluid leaks from fluid containing vessels
11/16/2004US6817225 Vapor trap system for detecting volatile organic chemical vapors
11/16/2004US6817222 Method, apparatus and system for assessing hair condition
11/16/2004US6817192 Device to record age of food
11/16/2004US6817170 Yarn monitoring
11/16/2004CA2525291A1 P. aeruginosa mucoid exopolysaccharide specific binding peptides
11/16/2004CA2466792A1 Evaluation of spectra
11/16/2004CA2379135C Test for brake fluid age and condition
11/16/2004CA2346975C Analytical rotors and methods for analysis of biological fluids
11/16/2004CA2346974C Analytical rotors and methods for analysis of biological fluids
11/16/2004CA2340714C Measuring energy consumption
11/16/2004CA2298856C Living tissue equivalents
11/16/2004CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/11/2004WO2004097577A2 Methods, software arrangements, storage media, and systems for providing a shrinkage-based similarity metric
11/11/2004WO2004097530A1 Structure and method for producing structure, toner containing structure, image forming method and device using toner
11/11/2004WO2004097429A2 Apociii and the treatmentand diagnosis of diabetes
11/11/2004WO2004097428A1 Screening method for identifying hsp90 modulators
11/11/2004WO2004097427A1 Methods for peptide analysis using mass spectrometry
11/11/2004WO2004097426A2 Methods and means for the treatment of disorders associated with cellular senescence
11/11/2004WO2004097425A2 Method of selecting chemokine antagonists and agonists
11/11/2004WO2004097424A1 Secreted polypeptide species reduced in cardiovascular disorders
11/11/2004WO2004097423A1 Secreted polypeptide species reduced cardiovascular disorders
11/11/2004WO2004097422A2 Diagnostics and therapeutics for diseases associated with calcitonin receptor (calcr)
11/11/2004WO2004097421A2 Diagnostics and therapeutics for diseases associated with calcitonin receptor-like receptor (calcrl)
11/11/2004WO2004097420A1 Method for the detection of a neurological dementia disease associated with a loss of short or long term memory, corresponding prosaas peptide and detection reagents
11/11/2004WO2004097419A1 Membrane strip biosensor system for point-of-care testing
11/11/2004WO2004097418A1 Method of diagnosis of foot and mouth disease and the diagnostic kit
11/11/2004WO2004097417A1 Structured construct and producing method therefor
11/11/2004WO2004097416A1 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for structure
11/11/2004WO2004097415A1 Biochip and biochip kit, and method of producing the same and method of using the same
11/11/2004WO2004097414A1 METHOD OF MEASURING INSULIN RECEPTOR α SUBUNIT
11/11/2004WO2004097413A1 Method for determining the concentration of an analyte
11/11/2004WO2004097412A2 Detection of analytes in fecal samples
11/11/2004WO2004097411A1 Novel screening method
11/11/2004WO2004097410A1 Screening methods for cataractogenic risk
11/11/2004WO2004097409A2 Hemostasis analyzer and method
11/11/2004WO2004097408A1 Drug discovery method and apparatus
11/11/2004WO2004097406A2 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION
11/11/2004WO2004097405A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor h7tba62 (h7tba62)
11/11/2004WO2004097404A1 Method for determination of the formation factor for a subterranean deposit from measurements on drilling waste removed therefrom
11/11/2004WO2004097403A1 Ligand profiling and identification
11/11/2004WO2004097400A1 Method and apparatus for analysing particulates
11/11/2004WO2004097399A2 Device and method for measuring the concentration of a pollutant in gaseous effluents
11/11/2004WO2004097395A1 Matrix for matrix aided laser desorption ionization mass analysis
11/11/2004WO2004097393A1 Filter and biosensor having the same
11/11/2004WO2004097390A1 Method and device for detecting volatile analytes in air samples
11/11/2004WO2004097388A1 Probe for measuring thermal and hydraulic properties
11/11/2004WO2004097376A1 Method and apparatus for detection of trace volatiles
11/11/2004WO2004097375A2 Method and device for drawing off liquid in particular transformer oil
11/11/2004WO2004097373A2 Thermoelectric biosensor for analytes in a gas
11/11/2004WO2004097372A2 Element-coded affinity tags
11/11/2004WO2004097370A2 Systems and methods for monitoring chemical and biolgical activities using differential measurements
11/11/2004WO2004097369A2 Fragmentation-based methods and systems for de novo sequencing
11/11/2004WO2004097368A2 Improved immunoassays
11/11/2004WO2004097367A2 Chromogenic substrate with a ph indicator dye
11/11/2004WO2004097358A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
11/11/2004WO2004097052A2 Methods for prognosis and treatment of solid tumors
11/11/2004WO2004097051A2 Methods for diagnosing aml and mds differential gene expression
11/11/2004WO2004097041A2 Screening method for binding molecules